novo nordisk glp-1 receptor agonist medications to launch Ozempic for type 2 diabetes in US Novo's Wegovy becomes first GLP-1

Preclinical data and practitioner observations suggest effects may occur within days

Safety is relative to peptide, dose, and source

The primary risk comes from unregulated products, which is why you should never purchase peptides on your own

Over the past decade or so, numerous diseases have been linked to ferroptosis as part of their etiology, including cancers, metabolic disorders, autoimmune diseases, central nervous system diseases, cardiovascular diseases, and musculoskeletal diseases

Such inhibition of the ETC causes NADH accumulation and feedback inhibition of the TCA cycle enzymes and pyruvate dehydrogenase which could explain reduced entry of glucose-derived pyruvate into the TCA cycle